Market Exclusive

Inc. (NASDAQ:INCR) Files An 8-K Submission of Matters to a Vote of Security Holders

Inc. (NASDAQ:INCR) Files An 8-K Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security
Holders.

On June29, 2017, Monogram Residential Trust,Inc. (the Company)
held its 2017 annual meeting of stockholders (the Annual Meeting)
in Plano, Texas. At the Annual Meeting, the Companys stockholders
voted in person or by proxy on (1)the election of seven directors
to serve until the 2018 annual meeting of stockholders and until
their successors are elected and qualified, (2)a non-binding,
advisory vote on the compensation of the Companys named executive
officers, and (3)the ratification of the appointment of Deloitte
Touche LLP as the Companys independent registered public
accounting firm for the year ending December31, 2017. The results
of the voting were as follows:

1. The following directors were elected to serve on the board of
directors until the 2018 annual meeting of stockholders and until
their respective successors are duly elected and qualified.

Name

VotesFor

VotesWithheld

BrokerNon-Votes

Mark T. Alfieri

116,376,524

1,411,350

35,113,376

David D. Fitch

105,007,762

12,780,112

35,113,376

Tammy K. Jones

105,047,422

12,740,452

35,113,376

Jonathan L. Kempner

104,536,895

13,250,979

35,113,376

W. Benjamin Moreland

112,901,645

4,886,229

35,113,376

E. Alan Patton

116,313,530

1,474,344

35,113,376

Timothy J. Pire

105,029,922

12,757,952

35,113,376

2. The Companys stockholders approved, on a non-binding advisory
basis, the compensation of the Companys named executive officers
as follows:

VotesFor

Against

Abstain

BrokerNon-Votes

114,160,176

2,503,569

1,124,129

35,113,376

3. The Companys stockholders ratified the appointment of Deloitte
Touche LLP as the Companys independent registered public
accounting firm for the fiscal year ending December31, 2017 as
follows:

VotesFor

Against

Abstain

151,579,649

346,632

974,969


Item 8.01. Other Events.

In connection with the Annual Meeting and effective June29,
2017, the Companys board of directors, based on the
recommendations of the nominating and corporate governance
committee, made the following appointments:

Audit Committee

Timothy J. Pire, Chairman

Tammy K. Jones

W. Benjamin Moreland

E. Alan Patton

Compensation Committee

David D. Fitch, Chairman

Jonathan L. Kempner

W. Benjamin Moreland

Timothy J. Pire

Nominating and Corporate Governance
Committee

Jonathan L. Kempner, Chairman

David D. Fitch

Tammy K. Jones

Timothy J. Pire


About Inc. (NASDAQ:INCR)
INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.

Exit mobile version